Patent · US Active

Vaccine

US9365624B2 · kind B2 · utility

2Cited by
1References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 11, 2011
Grant dateJun 14, 2016
Priority date
Expiry dateJul 16, 2031

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for the treatment or prevention of Gram-negative bacterial strain infection are provided herein. Methods for the manufacture of said compositions are also provided herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.